ARCHIVES

NCA Asks HHS To Exempt From DRG Peer Reviewed Institutions With At Least 25 Protocol Patients

This article is from The Cancer Letter archive.

Vol. 09 No. 32 | August 12, 1983

Download PDF Visit The Full Archive

Related Articles

Avastin Approved To Treat Progressive Glioblastoma

May 29, 2009

Duke Physician, BM, Patients, Lobby For Reimbursement

October 22, 1993

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

John Niederhuber Named Acting NCI Director.

June 2, 2006

Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded

September 28, 1990

Construction Needs From NCI Said $40 Million Year For Four Years

June 9, 1978